Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Roxane Verdikt
Top university
5 months ago
This position has expired. You can find similar positions from the section below or browse our positions listing pages.
PhD project on nuclear metabolism in tumour hypoxia KU Leuven in Belgium
Degree Level
PhD
Field of study
Cell Biology
Funding
Available
Deadline
Expired
Country
Belgium
University
KU Leuven
Suggested positions
Keywords
About this position
This PhD project, offered jointly by KU Leuven and UCLouvain, focuses on nuclear metabolism in tumour hypoxia, exploring the interface between nuclear metabolism, chromatin regulation, and single-cell epigenomics in cancer. The research will be conducted in collaboration between the Laboratory for Functional Epigenetics at KU Leuven and the Metabolic Research Group at the de Duve Institute, UCLouvain. Both institutions are located in Belgium, approximately 30 minutes apart, and provide access to a highly collaborative and internationally recognised biomedical research environment.
The project will employ molecular and cellular biology, metabolic approaches, and functional genomics to investigate how tumour hypoxia reshapes nuclear metabolic pathways and epigenetic regulation. Candidates will benefit from the complementary expertise, infrastructure, and scientific communities of both KU Leuven and UCLouvain. The research activities will be shared between both institutions, offering a unique opportunity to engage with diverse scientific teams and resources.
Applicants should have a Master’s degree in biochemistry, molecular biology, biomedical sciences, or bioengineering. Hands-on experience with mammalian cell culture and standard molecular biology techniques is essential. The ideal candidate will possess strong scientific curiosity and motivation for fundamental cancer research, as well as excellent communication and organisational skills. Experience with epigenomics, omics data analysis, cancer models, or metabolic assays is considered an asset.
The position is open until filled, with a formal application deadline of June 15, 2026. Applications should include a CV, a short motivation letter, contact information for two referees, and optionally a brief description of previous research experience or technical expertise relevant to the project. For more information, prospective candidates are encouraged to contact Dr. Roxane Verdikt or Prof. Bernard Thienpont via email.
KU Leuven is committed to fostering an inclusive, respectful, and socially safe environment, embracing diversity as an asset and promoting equal opportunity. The university does not accept any form of discrimination and offers support for accessibility and other needs.
This PhD opportunity is ideal for candidates interested in cancer research, nuclear metabolism, and epigenomics, and who wish to work in a dynamic, international academic setting.
Funding details
Available
What's required
Applicants must hold a Master’s degree in biochemistry, molecular biology, biomedical sciences, or bioengineering. Hands-on experience with mammalian cell culture and standard molecular biology techniques is required. Candidates should demonstrate strong scientific curiosity and motivation for fundamental cancer research, as well as excellent communication and organisational skills. Experience with epigenomics, omics data analysis, cancer models, or metabolic assays is considered an asset.
Make your next move.
Prepare your application
Review drafts and confirm requirements with the university.
Professors
Prof. dr. at KU Leuven
Belgium
Research Interests
Cell Biology
Biochemistry
Epigenetic
Single-cell Analysis
Medical Science
Prof. at KU Leuven
Belgium
Research Interests
Biochemistry
Cell Biology
Bio Engineering
Metabolic Pathways
Molecular Biology
Make your next move.
Prepare your application
Review drafts and confirm requirements with the university.